American Association for Cancer Research

SHERPA: White

People

  1. Bertino
    Bertino
  2. Rosen
    Rosen
  3. Scher
    Scher
  4. Cordon-Cardo
    Cordon-Cardo
  5. Banerjee
    Banerjee
  6. Ladanyi
    Ladanyi
  7. Solit
    Solit
  8. Spriggs
    Spriggs
  9. Heston
    Heston
  10. De Stanchina
    De Stanchina

Groups

  1. Department of Medicine (759)
  2. GSK Faculty (569)
  3. Solid Tumor Oncology Division (542)
  4. Sloan Kettering Institute Faculty (386)
  5. Sloan Kettering Institute Postdocs (266)
  6. Surgery (257)
  7. Epidemiology and Biostatistics (240)
  8. Population Sciences Research Program (236)
  9. Molecular Pharmacology and Chemistry Program Faculty (221)
  10. Center for Hematologic Malignancies (218)
Search Within
Formats
  1. Meeting Abstract (1046)
  2. Journal Article (782)
  3. Editorial (36)
  4. Review (27)
Groups
  1. Department of Medicine (759)
  2. GSK Faculty (569)
  3. Solid Tumor Oncology Division (542)
  4. Sloan Kettering Institute Faculty (386)
  5. Sloan Kettering Institute Postdocs (266)
  6. Surgery (257)

More Groups

People
  1. Joseph Bertino (93)
  2. Neal Rosen (70)
  3. Howard Scher (58)
  4. Carlos Cordon-Cardo (54)
  5. Debabrata Banerjee (47)
  6. Marc Ladanyi (44)

More People

Years
  1. 2025 (32)
  2. 2024 (63)
  3. 2023 (65)
  4. 2022 (71)
  5. 2021 (62)
  6. 2020 (85)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (924)
  2. Cancer Discovery (294)
  3. Cancer Epidemiology Biomarkers and Prevention (249)
  4. Molecular Cancer Therapeutics (124)
  5. Cancer Immunology Research (103)
  6. Molecular Cancer Research (68)

More Publications

Results (1891)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MRTX1719 is an MTA-cooperative PRMT5 inhibitor that exhibits synthetic lethality in preclinical models and patients with MTAP-deleted cancer
    Journal Article

    Engstrom, L. D.; Aranda, R.; Waters, L.; Moya, K.; Bowcut, V.; Vegar, L.; Trinh, D.; Hebbert, A.; Smith, C. R.; Kulyk, S.; more...
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • An embarrassment of riches: Three FDA-approved bispecific antibodies for relapsed refractory multiple myeloma
    Review

    Firestone, R.; Lesokhin, A. M.; Usmani, S. Z.
    Blood Cancer Discovery (2023)

    Fulltext@MSK | Save
  • The clinicopathological and psychosocial profile of a cohort of Nigerian breast cancer survivors
    Meeting Abstract

    Wuraola, F.; Olasehinde, O.; Di Bernardo, M.; Mango, V.; Kingham, T. P.; Adisa, A.; Alatise, O.
    Cancer Epidemiology Biomarkers and Prevention (2023)

    Fulltext@MSK | Save
  • Does receipt of resource-adapted guideline-concordant breast cancer care improve outcomes? A Retrospective study of 517 breast cancer patients in southwest Nigeria
    Meeting Abstract

    Dare, A.; Olasehinde, O.; Di Bernardo, M.; Wuraola, F.; Omisore, L.; Omoyiola, T.; Owoade, I.; Ogunyemi, M.; Kahn, R.; Kingham, T. P.; more...
    Cancer Epidemiology Biomarkers and Prevention (2023)

    Fulltext@MSK | Save
  • Targeting JAK1 signaling for molecular prevention in clonal hematopoiesis
    Meeting Abstract

    Sánchez Vela, P.; Benitez, A. M.; Krishnan, A.; Kleppe, M.; Cai, S. F.; Levine, R. L.
    Cancer Prevention Research (2023)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and risk of lethal prostate cancer: a prospective cohort study with long-term follow-up
    Meeting Abstract

    Stopsack, K. H.; Chan, I. C.; Schmidt, E.; Panchot, A.; McNulty, S.; Schreiber, N. A.; Zhang, Y. W.; Penney, K. L.; Berger, M. F.; Diaz, L. A.; more...
    Cancer Prevention Research (2023)

    Fulltext@MSK | Save
  • Characterizing the immune microenvironment updates and neoantigen landscape of Hürthle cell carcinoma to identify potential immunologic vulnerabilities
    Journal Article

    Ganly, I.; Kuo, F.; Makarov, V.; Dong, Y.; Ghossein, R.; Xu, B.; Morris, L. G. T.; Chan, T. A.
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • Tumor-targeted nonablative radiation promotes solid tumor CAR T-cell therapy efficacy
    Journal Article

    Quach, H. T.; Skovgard, M. S.; Villena-Vargas, J.; Bellis, R. Y.; Chintala, N. K.; Amador-Molina, A.; Bai, Y.; Banerjee, S.; Saini, J.; Xiong, Y.; more...
    Cancer Immunology Research (2023)

    Fulltext@MSK | Save
  • Genetic susceptibility to nonalcoholic fatty liver disease and risk for pancreatic cancer: Mendelian randomization
    Journal Article

    King, S. D.; Veliginti, S.; Brouwers, M. C. G. J.; Ren, Z.; Zheng, W.; Setiawan, V. W.; Wilkens, L. R.; Shu, X. O.; Arslan, A. A.; Beane Freeman, L. E.; more...
    Cancer Epidemiology Biomarkers and Prevention (2023)

    Fulltext@MSK | Save
  • Molecular characterization of acquired resistance to KRAS(G12C)-EGFR inhibition in colorectal cancer
    Meeting Abstract

    Misale, S.
    Molecular Cancer Research (2023)

    Fulltext@MSK | Save